Pfizer (NYSE:PFE) is currently dealing with shareholder proposals concerning governance issues such as religious ...

The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Sponsored by the Indian Council of Social Science Research (ICSSR), the seminar served as a platform for experts, researchers, and students to discuss the role of artificial intelligence (AI) in ...

Núñez Feijóo, the leader of the Spanish People's Party (Partido Popular/EPP), the main opposition force in Parliament, met with Sánchez (PSOE/S&D) for talks on how the government intends to reach its ...

A 400-home neighbourhood at Hazelhurst Farm in Worsley, a site allocated in Greater Manchester’s Places for Everyone development plan, will go to committee for a decision next week.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...

Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...

Tariffs are taxes on imports, used to protect domestic industries, generate revenue, and influence trade policies. Trump's ...